Robert Glazier

Latest post: 9/26/2017
In June 2013 I was diagnosed with pancreatic cancer. Pancreatic cancer is a very difficult cancer, with a five-year survival rate of only eight percent. The only potential cure for pancreatic cancer is a harsh operation, called a “Whipple,” in which parts of the pancreas and other organs are removed, and the remaining organs are sewn together.

After chemotherapy and radiation I became eligible for the surgery, which was performed in March 2014. The surgery was successful, and all of the visible cancer was removed. But even when it appears that all the cancer has been removed by surgery, pancreatic cancer frequently recurs. The cancer returned In August 2014, and my doctors determined that it had spread elsewhere in my body. I then went on a year of rigorous chemotherapy which made the tumors disappear on scans. In August 2015 I went on a lighter, maintenance chemotherapy. For about fifteen months the cancer was  not visible on scans. In November 2016 a small growth was found in my pancreas, and I then began a more rigorous chemotherapy.  As of Summer 2017, the chemotherapy has been successful in keeping the cancer in check.  

In April 2016 I told my story to an event sponsored by the Miami affiliate of the Pancreatic Cancer Action Network. The video of my talk is online (https://youtu.be/cVZ3Ls9H2gc). In November 2016 I was interviewed for the Jewbalations podcast (https://www.spreaker.com/user/backroomstewdios/jewbalations-robert-glazier). You can read about one of my passions here: http://www.sun-sentinel.com/florida-jewish-journal/news/miami-dade/fl-jjdc-fund-0705-20170630-story.html 

CaringBridge is a nonprofit social network dedicated to helping family and friends communicate with and support loved ones during a health journey. Learn more about CaringBridge.

To interact with Robert’s website, sign in or register today.

By registering with CaringBridge, you will join over 300,000 people a day who are supporting friends and family members.

Sign In Or Register
SVG_Icons_Back_To_Top
Top